Plain-English translation of NCT04160910 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This trial is testing whether 5HTP, a natural supplement derived from a plant, can help children with allergic asthma improve their lung function and reduce anxiety or depression symptoms. About half of the children will receive the medication, and half will receive a placebo (a pill with no active ingredient), so researchers can see if the treatment actually works. The study will measure changes in how well the children's lungs function and track their anxiety and depression scores over time.
Many children with asthma also struggle with anxiety and depression, and current treatments don't always address both problems well. Early research suggests this medication might help reduce the lung inflammation that makes asthma worse and also improve mood, which could transform how doctors treat allergic asthma in kids.
You likely qualify if…
You likely don't qualify if…
If you join this study, you'll take either the supplement or a placebo twice a day by mouth — the dose depends on your weight. You'll come to research visits where doctors will test your lung function, check your eosinophil counts (a type of white blood cell related to allergies), and ask you questions about your asthma symptoms and mood. The study involves blood and nasal fluid samples to help researchers understand how the medication is working in your body.
AI-generated summary from trial data · Jun 2, 2026 · Not medical advice
United States